The results showed an increase in phospho-FAK (S910), the ERK1/2 phosphorylation site, in YUDOSO-BRAFWT and a reduction in YULAC-BRAFV600E melanoma cells (Figure 6B, pFAK S910). Here, PTK2 is linked to melanoma.